Onset of Effect, Changes in Airflow Obstruction and Lung Volume, and Health-Related Quality of Life Improvements with Benralizumab for Patients with Severe Eosinophilic Asthma: Phase IIIb Randomized, Controlled Trial (SOLANA)

Onset of Effect, Changes in Airflow Obstruction and Lung Volume, and Health-Related Quality of Life Improvements with Benralizumab for Patients with Severe Eosinophilic Asthma: Phase IIIb Randomized, Controlled Trial (SOLANA)

Reynold A Panettieri Jr,1 Tobias Welte,2 Kartik V Shenoy,3 Stephanie Korn,4 Margret Jandl,5 Edward M Kerwin,6 Rosa Feijoo,7 Peter Barker,8 Richard F Olsson,9 Ubaldo J Martin8 On behalf of the SOLANA Study Investigators1Pulmonary, Allergy and Critical Care Division, University of Pennsylvania, Philad...

Full description

Bibliographic Details
Main Authors: Panettieri RA Jr, Welte T, Shenoy KV, Korn S, Jandl M, Kerwin EM, Feijoo R, Barker P, Olsson RF, Martin UJ
Format: Article
Language:English
Published: Dove Medical Press 2020-02-01
Series:Journal of Asthma and Allergy
Subjects:
anti–il-5rα
benralizumab
interleukin-5
randomized controlled trial
eosinophilic
severe asthma 
Online Access:https://www.dovepress.com/onset-of-effect-changes-in-airflow-obstruction-and-lung-volume-and-hea-peer-reviewed-article-JAA

Internet

https://www.dovepress.com/onset-of-effect-changes-in-airflow-obstruction-and-lung-volume-and-hea-peer-reviewed-article-JAA

Similar Items